LONDON, ENGLAND, UNITED KINGDOM, May 25, 2017 /EINPresswire.com/ -- With more companies moving into the peptides therapeutic field and the market projected to continue its growth, SMi’s 4th annual Peptides Conference even will highlight four exclusive presentations dedicated to improving future peptide development.

• Peptides in the Biopharmaceutical Industry Today and Tomorrow
Frank Thielmann, PMO & Operational Excellence Lead, Novartis
A presentation on industrial pipelines and disease areas addressed by biotherapies, benefits and differences in development and manufacturing of peptides, NBEs vs NCEs and future trends in manufacturing.

• Conquering a Peptide Optimisation Challenge Using Protein Engineering Techniques and Deliberate Potency Reduction
Jonathan Davis, Principal Scientist, Bristol-Myers Squibb
Case studies on optimising gp41-binding peptide as a component of a tri-functional therapeutic and how final peptide becomes part of a tri-specific biologic therapeutic with picomolar potency and broad spectrum against HIV

• Optimisation of Peptide Stability
Martin Will, Section Head MedChem, Sanofi
A session on physical and chemical stability, as well as methods for determination of physical and chemical stability of peptides

• ReadyFlow – A First in Class Coagulant for Controlling Surgical Bleeding
Renata Zbozien, Vice President R&D, Haemostatix
A talk about the unmet needs in the control of surgical bleeding and key factors to determine success including a discussion about HX-P12 peptide, a first in class peptide coagulant.

Other presentations will focus on crucial topics within the peptides landscape including the extension of half-life and liquid chromatography and mass spectrometry led by experts from UCB, IRBM, Proxima Concepts, Pfizer, Boehringer-Ingelheim, Ipsen, Nestlé Skin Health, Sanofi, Albumedix, Ferring, and more.

The full roster of speakers and their presentation details can be found on www.peptidesevent.com/EIN.

4th Peptides Event
6-7 July 2017
Holiday Inn Kensington Forum, London UK
www.peptidesevent.com/EIN

--- END ---
For delegate registration enquiries, contact Fateja Begum on fbegum@smi-online.co.uk. For media enquiries, contact Honey de Gracia at hdegracia@smi-online.co.uk.
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Teri Arri
SMi Group
2078276000
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.